Nadia N. Laack, M.D.
Mayo Clinic
3
1
3
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+7 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
M. Sue O'Dorisio, MD, PhD
University of Iowa
Shared therapeutic areas:
Stephen Michael Hahn
Abramson Cancer Center at Penn Medicine
Shared therapeutic areas:
Wenyin Shi, MD, PhD
Thomas Jefferson University
Shared therapeutic areas:
Suzanne Danhauer
Wake Forest University Health Sciences
Shared therapeutic areas:
Antonius Miller
Cancer and Leukemia Group B
Shared therapeutic areas:
Glenn Lesser
Wake Forest University Health Sciences
Shared therapeutic areas:
Jana Portnow
City of Hope Medical Center
Shared therapeutic areas:
Robert Lustig
Abramson Cancer Center at Penn Medicine
Shared therapeutic areas:
Jeffrey Raizer, MD
Northwestern University
Shared therapeutic areas:
Howard Fine, MD
North American Brain Tumor Consortium
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
All 3 trials loaded